Mitochondrial-Lysosomal Axis in Acetaminophen Hepatotoxicity

Area of Science:

• Hepatology
• Toxicology
• Cell Biology

Background:

• Acetaminophen (APAP) overdose is a leading cause of acute liver failure (ALF) and liver transplantation.
• APAP metabolism generates a reactive metabolite, NAPQI, which can cause mitochondrial damage and cell death.
• Effective therapies for APAP-induced ALF are urgently needed.

Purpose of the Study:

• To review the role of mitochondria in APAP hepatotoxicity.
• To explore the influence of the mitochondrial/lysosomal axis on APAP-induced liver injury.
• To highlight mitophagy as a potential therapeutic strategy.

Main Methods:

• Literature review focusing on molecular mechanisms of APAP hepatotoxicity.
• Analysis of studies investigating mitochondrial dysfunction and mitophagy in APAP overdose.
• Examination of the interplay between lysosomes and mitochondria in regulating cell death pathways.

Main Results:

• Mitochondria are primary targets of APAP toxicity, leading to oxidative stress and dysfunction.
• Mitophagy, the clearance of damaged mitochondria, is crucial for preventing APAP-induced liver injury.
• Lysosomal impairment compromises mitophagy, exacerbating APAP hepatotoxicity.

Conclusions:

• Mitochondrial dysfunction is central to APAP-induced acute liver failure.
• The mitochondrial-lysosomal crosstalk is a critical regulator of APAP hepatotoxicity.
• Targeting mitophagy and lysosomal function presents a promising therapeutic avenue for APAP-induced ALF.